Literature DB >> 3499219

Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion.

M D Ellison1, J T Povlishock, R E Merchant.   

Abstract

The effects of systemic human recombinant interleukin-2 (rIL-2) infusion upon blood-brain barrier status and cerebral vascular ultrastructure were examined in cats. Each of eight animals received a single bolus i.v. infusion of rIL-2 (100,000 units/kg). Six control animals were infused with rIL-2 excipient only. Following a 1-h postinfusion survival time, the brain tissue of five rIL-2 infused and three excipient infused animals was processed and examined by light microscopy and electron microscopy for evidence of altered cerebrovascular permeability to systemically circulating horseradish peroxidase. The brain tissue of three additional rIL-2 infused animals and three excipient infused animals, sacrificed 4 h postinfusion, was examined at the light microscopic and electron microscopic levels for the presence of extravasated endogenous IgG. All animals infused with rIL-2 and four of six excipient infused animals showed increased cerebrovascular permeability to the probe used. Altered blood-brain barrier permeability, when present, was recognized in multiple loci throughout the brain, being most prominent within white matter regions. Horseradish peroxidase and IgG were observed within perivascular basal laminae and within the interstices of the brain parenchyma. Numerous endothelial lesions were observed as was flooding of endothelial cytoplasm by horseradish peroxidase or IgG. Every animal studied, regardless of permeability status, showed, within the perivascular brain parenchyma, numerous disrupted neuronal and glial processes as well as expanded intercellular spaces. This study suggests that a single systemic infusion of rIL-2 profoundly alters blood-brain barrier integrity and cerebrovascular morphological integrity. The data also suggest that some of the observed cerebrovascular effects of systemic rIL-2 infusion are due to components of the vehicle for rIL-2.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499219

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

Review 1.  Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier.

Authors:  Michelle A Erickson; Kenji Dohi; William A Banks
Journal:  Neuroimmunomodulation       Date:  2012-01-11       Impact factor: 2.492

2.  Cytokines and Postoperative Delirium in Older Patients Undergoing Major Elective Surgery.

Authors:  Sarinnapha M Vasunilashorn; Long Ngo; Sharon K Inouye; Towia A Libermann; Richard N Jones; David C Alsop; Jamey Guess; Sandra Jastrzebski; Janet E McElhaney; George A Kuchel; Edward R Marcantonio
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-07-27       Impact factor: 6.053

Review 3.  Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal.

Authors:  R D Broadwell
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes.

Authors:  C D Rice; N G Baldwin; R T Biron; H D Bear; R E Merchant
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

Review 5.  Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations.

Authors:  R E Merchant; M D Ellison; H F Young
Journal:  J Neurooncol       Date:  1990-04       Impact factor: 4.130

6.  Effects of interleukin 2 on cardiac function in the isolated rat heart.

Authors:  P A Sobotka; J McMannis; R I Fisher; D G Stein; J X Thomas
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

7.  Blood-borne interleukin-1 alpha is transported across the endothelial blood-spinal cord barrier of mice.

Authors:  W A Banks; A J Kastin; C A Ehrensing
Journal:  J Physiol       Date:  1994-09-01       Impact factor: 5.182

8.  Absence of cortical demyelination in neuromyelitis optica.

Authors:  B F Gh Popescu; J E Parisi; J A Cabrera-Gómez; K Newell; R N Mandler; S J Pittock; V A Lennon; B G Weinshenker; C F Lucchinetti
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

9.  Inflammation as a mediator of the relationship between cortical thickness and metabolic syndrome.

Authors:  Sonya S Kaur; Mitzi M Gonzales; Danielle E Eagan; Katyoon Goudarzi; Hirofumi Tanaka; Andreana P Haley
Journal:  Brain Imaging Behav       Date:  2015-12       Impact factor: 3.978

10.  Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat.

Authors:  J L Wright; R E Merchant
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.